• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

A New Stage Classification of Pancreatic Cancer Including Cytomolecular Factors

Research Project

Project/Area Number 08457301
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionShimane Medical University

Principal Investigator

TAMURA Katsuhiro  Shimane Medical University, 1st Dept.of Surgery, Professor, 医学部, 教授 (80155259)

Co-Investigator(Kenkyū-buntansha) NIO Yoshinori  Shimane Medical University, 1st Dept.of Surgery, Associate Professor, 医学部, 助教授 (20208119)
Project Period (FY) 1996 – 1997
Keywordspancreatic cancer / clinical stage / oncogene / tumor suppressor gene / growth factor / prognostic factor
Research Abstract

The present project was designed to develope a new clinical stage classification of pancreatic cancer. The previous classification included just clinicopathological factors, but pancreatic cancer can not always be classified by this standard stage, because pancreatic cancer shows extremely malignant potentials. In the present study, we assessed the cytomolecular backgrounds of pancreatic cancer using various gene techniques and immunohistochemistry with monoclonal antibodies. The cytomolecular factors included Ki-ras point mutation and the expression of p53 tumor suppressor gene product, EGF and its receptor, fibronectin and Ki-ras p21.
The results show that the expression of p53 tumor suppressor gene product, coexpression of EGF and EGF-receptor, and Ki-ras double mutation were suggested to be the indicators for poor prognosis of the patients with pancreatic cancer, independently of clinicopathological factors such as depth of tumor invasion, nodal involvement or distant metastasis.
We conclude that these cytomolecular parameters are beneficial to predict the prognosis of the pancreatic cancer patients and the clinical stage should include the status of these parameters.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Mao-Min Song 他: "Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas" International Journal of Pancreatology. 20.2. 85-93 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 平原 典幸 他: "膵癌におけるfibronectin発現と臨床病理学的因子との関係に関する研究" 日本消化器外科学会雑誌. 29.9. 1881-1890 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshinori Nio 他: "Ki-ras point mutation in codon 12 and expression of p53 in mucin-producing tumor of the pancreas." J Hep Bil Pancr Surg. 4.1. 83-90 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshitoshi Sato 他: "p53 Protein Expression as Prognostic Factor in Human Pancreatic Cancer" Anticancer Research. 17.4A. 2779-2788 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ken Uegaki 他: "Clinicopathological Significance of Epidermal Growth Factor and its Receptor in Human Pancreatic Cancer" Anticancer Research. 17.5B. 3841-3847 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三成 善光 他: "膵癌におけるThymidine phosphorylase発現の免疫組織学的検討とその臨床病理学的意義" 日本癌治療学会誌. 32.4. 315-325 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Dong Ming 他: "Comparative Study on Expression of p53 Protein in Primary Invasive Ductal Carcinoma of the Pancreas between Chinese and Japanese." Pancreas. 16(印刷中). (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Noriyuki Hirahara, et al.: "Clinicopathological siggnificance of the expression of fibronectin in human pancreatic cancer." The Japanese Journal of Gastroenterological Surgery. 29 (9). 1881-1890 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mao-Min Song, et al.: "Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas" International Journal of Pancreatology. 20 (2). 85-93 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshinori Nio, et al.: "Ki-ras point mutation in codon 12 and expression of p53 in mucin-producing tumor of the pancreas." j Hep Bil Pancr Surg. 4 (1). 83-90 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshitoshi Sato, et al.: "p53 protein expression as prognostic factor in human pancreatic cancer." Anticancer Research. 17 (4A). 2779-2788 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ken Uegaki, et al: "Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer" Anticancer Research. 17 (5B). 3841-3848 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshimitsu Minari, et al.: "The clinicopathological significance of thymidine phosphorylase in human pancreatic cancer : Its different distribution between the primary and the metastatic lesions." The Journal of Japan Society for Cancer Therapy. 32 (4). 315-325 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Dong Ming, et al.: "Comparative study on expression of p53 protein in primary invasive ductal carcinoma of the pancreas between Chinese and Japanese." Pancreas. 16 (in press). (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi